Inhibitory Effects of Belatacept on Allospecific Regulatory T-Cell Generation in Humans
出版年份 2013 全文链接
标题
Inhibitory Effects of Belatacept on Allospecific Regulatory T-Cell Generation in Humans
作者
关键词
-
出版物
TRANSPLANTATION
Volume 96, Issue 8, Pages 689-696
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2013-07-24
DOI
10.1097/tp.0b013e31829f1607
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CTLA4-Ig Restores Rejection of MHC Class-II Mismatched Allografts by Disabling IL-2-Expanded Regulatory T Cells
- (2012) L.-M. Charbonnier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Deleterious Effect of CTLA4-Ig on a Treg-Dependent Transplant Model
- (2012) L. V. Riella et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Ex Vivo Alloanergization with Belatacept: A Strategy to Selectively Modulate Alloresponses after Transplantation
- (2012) Jeff K. Davies et al. CELL TRANSPLANTATION
- Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients
- (2012) Josh Levitsky et al. HEPATOLOGY
- Belatacept and Tregs: friends or foes?
- (2012) Nina Pilat et al. Immunotherapy
- Ligation of Cytotoxic T Lymphocyte Antigen-4 to T Cell Receptor Inhibits T Cell Activation and Directs Differentiation into Foxp3+Regulatory T Cells
- (2012) Jozsef Karman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-Term Effects of Alemtuzumab on Regulatory and Memory T-Cell Subsets in Kidney Transplantation
- (2012) Camila Macedo et al. TRANSPLANTATION
- Immunosuppression, Generic Drugs and the FDA
- (2011) G. B. Klintmalm AMERICAN JOURNAL OF TRANSPLANTATION
- Selective CD28 Blockade Attenuates Acute and Chronic Rejection of Murine Cardiac Allografts in a CTLA-4-Dependent Manner
- (2011) T. Zhang et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Favorable effects of alemtuzumab on allospecific regulatory T-cell generation
- (2011) Josh Levitsky et al. HUMAN IMMUNOLOGY
- Allospecific Regulatory Effects of Sirolimus and Tacrolimus in the Human Mixed Lymphocyte Reaction
- (2011) Josh Levitsky et al. TRANSPLANTATION
- Different Immunosuppressive Combinations on T-Cell Regulation in Renal Transplant Recipients
- (2010) Costas Fourtounas et al. AMERICAN JOURNAL OF NEPHROLOGY
- A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
- (2010) A. Durrbach et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
- (2010) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CD28 Facilitates the Generation of Foxp3- Cytokine Responsive Regulatory T Cell Precursors
- (2010) C. W. J. Lio et al. JOURNAL OF IMMUNOLOGY
- High Levels of IDO-Expressing CD16+ Peripheral Cells, and Tregs in Graft Biopsies From Kidney Transplant Recipients Under Belatacept Treatment
- (2010) J. Furuzawa-Carballeda et al. TRANSPLANTATION PROCEEDINGS
- Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents
- (2009) Josh Levitsky et al. HUMAN IMMUNOLOGY
- CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population
- (2009) Hyeok-Jae Ko et al. JOURNAL OF AUTOIMMUNITY
- The Human “Treg MLR”: Immune Monitoring for FOXP3+ T Regulatory Cell Generation
- (2009) Josh Levitsky et al. TRANSPLANTATION
- Conversion From Calcineurin Inhibitor to Mycophenolate Mofetil-Based Immunosuppression Changes the Frequency and Phenotype of CD4+FOXP3+ Regulatory T Cells
- (2009) Ahmet Demirkiran et al. TRANSPLANTATION
- Differential Effect of Cyclosporine and Mycophenolic Acid on the Human Regulatory T Cells and TH-17 Cells Balance
- (2009) F. Abadja et al. TRANSPLANTATION PROCEEDINGS
- The Effect of Costimulatory and Interleukin 2 Receptor Blockade on Regulatory T Cells in Renal Transplantation
- (2008) J. A. Bluestone et al. AMERICAN JOURNAL OF TRANSPLANTATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started